Ophthalmology Times - Ophthalmology news, articles, and events
WEBEyeCon 2024: Key takeaways for enhanced patient care from Day 1. This Week in Ophthalmology: Week of September 22, 2024. EyeCon 2024: Peter McDonnell, MD, and Laura Periman, MD, on the importance of integrating new knowledge into practice. Eyecon 2024: Thyroid Eye Disease in focus. Retina Society 2024: A …
Physicians sort out pros and cons of several new IOLs on the market
WEBNov 12, 2021 — The new IOL in the EDoF category is the AcrySof IQ Vivity (Alcon). The Vivity uses wavefront-shaping technology on its anterior surface that elongates the depth of focus, giving about a 1.5 D range of vision. Because it is a nondiffractive lens, risks of glare and halos are minimized and quality of vision is better than with a multifocal IOL.
FDA approves eye drops for treatment of presbyopia
WEBOct 30, 2021 — Allergan developed VUITY, which it noted is the first and only FDA-approved eye drop to treat presbyopia. Allergan, an AbbVie company, announced FDA approval of pilocarpine HCl ophthalmic solution 1.25% (VUITY) for the treatment of presbyopia, commonly known as age-related blurry near vision, in adults. According to the company, pilocarpine HCl ...
Early clinical experience with next-generation lens
WEBMar 13, 2021 — Early clinical experience with next-generation lens. March 13, 2021. By Cheryl Guttman Krader, BS, Pharm. Publication. Article. Digital Edition Ophthalmology Times: March 15, 2021. Volume 46. Issue 5. One surgeon shares the early results of his experience using the new TECNIS Eyhance and TECNIS Eyhance Toric II IOLs in performing the first post ...
Managing conjunctival pigmented lesions - Ophthalmology Times
WEBJun 15, 2017 — Conjunctival nevus tends to be pigmented and asymptomatic with a low risk for transformation into melanoma, somewhere under 1%, said Dr. Shields, co-director, Oncology Service, Wills Eye Hospital, and professor of ophthalmology at Thomas Jefferson University in Philadelphia. PAM tends to occur in Caucasians, is …
Glaucoma + nutrition: why what you eat matters - Ophthalmology …
WEBJul 12, 2021 — Bananas, avocados, pumpkin seeds, and black beans are great sources to help you meet the recommended daily allowance of 300-400 magnesium. Though more research is needed, preliminary studies suggest that dietary magnesium may benefit people with glaucoma by improving blood flow to the eye. It …
Measuring RNFL with OCT detects subtle differences in glaucoma …
WEBJan 11, 2020 — OCT can detect structural RNFL abnormalities and progression. OCT outperforms measurement of the visual fields (VFs) in detecting progression in early glaucoma. VF progression can be measured even when the VF is normal. In cases of moderate and advanced glaucoma, RNFL progression rate decreases due to a floor effect.
Myths and misconceptions about autologous serum for dry eye
WEBJun 22, 2020 — Special to Ophthalmology Times® Autologous serum eye drops (ASEDs) have become a mainstay of therapy for certain categories of patients with dry eye and those with underlying immunologic disease or poor epithelial healing.. The logistics of prescribing ASEDs have changed dramatically in the past few years, making their use far more convenient for patients and physicians alike.
Dealing with positive and negative dysphotopsias
WEBOct 4, 2019 — Positive dysphotopsias are most often characterized by persistent bright rings, flares, arcs, halos, and flashes that most often appear when light is coming into. the eye from the side, such as the oncoming headlights of another vehicle. The long term incidence may be as high as 1.5% and can vary greatly by IOL type, material, and design.
Fluorometholone acetate: More benefit than meets the eye
WEBDec 11, 2019 — Fluorometholone is the active steroid in formulations used to treat ocular inflammation- however, it is what doesn’t meet the eye that makes the difference, i.e., the vehicle. If the vehicle prevents the drug from optimally penetrating through the ocular surface into the underlying tissue, the drug will not be as effective as if the ...